MX373323B - Procesos de siembra en serie y usos de los mismos. - Google Patents

Procesos de siembra en serie y usos de los mismos.

Info

Publication number
MX373323B
MX373323B MX2016016301A MX2016016301A MX373323B MX 373323 B MX373323 B MX 373323B MX 2016016301 A MX2016016301 A MX 2016016301A MX 2016016301 A MX2016016301 A MX 2016016301A MX 373323 B MX373323 B MX 373323B
Authority
MX
Mexico
Prior art keywords
serial
sowing processes
processes
sowing
seed train
Prior art date
Application number
MX2016016301A
Other languages
English (en)
Other versions
MX2016016301A (es
Inventor
Benjamin Wright
Konstantin Konstantinov
Michael Bruninghaus
Weichang Zhou
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53477008&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX373323(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of MX2016016301A publication Critical patent/MX2016016301A/es
Publication of MX373323B publication Critical patent/MX373323B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/28—Constructional details, e.g. recesses, hinges disposable or single use
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/58—Reaction vessels connected in series or in parallel
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M27/00—Means for mixing, agitating or circulating fluids in the vessel
    • C12M27/16—Vibrating; Shaking; Tilting
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/10—Perfusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0031—Serum-free culture media
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0062—General methods for three-dimensional culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2511/00—Cells for large scale production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Sustainable Development (AREA)
  • Cell Biology (AREA)
  • Clinical Laboratory Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a un método para producir una proteína recombinante que comprende: (a) colocar múltiples células de mamífero recombinante en un primer medio de cultivo comprendido dentro de un recipiente para proporcionar un primer cultivo celular; (b) cultivar por lotes el primer cultivo celular hasta un intervalo de densidad celular de aproximadamente 1.0 x 106 células/mL a aproximadamente 5.0 x 106 células/mL; (c) colocar un volumen del primer cultivo celular de la etapa (b) en un segundo medio de cultivo incluido dentro de un biorreactor de perfusión para proporcionar un segundo cultivo celular con una densidad celular inicial en un intervalo de aproximadamente 0.25% x 106 células/mL a aproximadamente 0.5 x 106 células/mL; ( e) colocar un volumen del segundo cultivo celular de la etapa (d) en un tercer medio de cultivo incluido dentro de un biorreactor de producción para proporcionar un cultivo celular de producción con una densidad celular inicial en un intervalo de aproximadamente 0.25% y 106 células/mL a aproximadamente 8 x 106 células/mL; (f) cultivar por perfusión el cultivo celular de producción en condiciones que permitan que las células de mamíferos recombinantes secreten una proteína recombinante; y (g) recolectar la proteína recombinante del cultivo celular de producción.
MX2016016301A 2014-06-09 2015-06-08 Procesos de siembra en serie y usos de los mismos. MX373323B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462009553P 2014-06-09 2014-06-09
PCT/US2015/034709 WO2015191462A1 (en) 2014-06-09 2015-06-08 Seed train processes and uses thereof

Publications (2)

Publication Number Publication Date
MX2016016301A MX2016016301A (es) 2017-04-06
MX373323B true MX373323B (es) 2020-05-04

Family

ID=53477008

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2016016301A MX373323B (es) 2014-06-09 2015-06-08 Procesos de siembra en serie y usos de los mismos.
MX2020004073A MX2020004073A (es) 2014-06-09 2016-12-08 Procesos de siembra en serie y usos de los mismos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2020004073A MX2020004073A (es) 2014-06-09 2016-12-08 Procesos de siembra en serie y usos de los mismos.

Country Status (18)

Country Link
US (2) US10570367B2 (es)
EP (3) EP3628730A1 (es)
JP (3) JP6784600B2 (es)
KR (2) KR102584375B1 (es)
CN (2) CN106574249B (es)
AU (3) AU2015274897B2 (es)
BR (1) BR112016028891B1 (es)
CA (1) CA2951551C (es)
CY (1) CY1122803T1 (es)
DK (1) DK3152299T3 (es)
ES (2) ES3043610T3 (es)
HU (1) HUE047683T2 (es)
IL (3) IL290096B2 (es)
MX (2) MX373323B (es)
RU (1) RU2694327C2 (es)
SG (1) SG11201610216UA (es)
TW (3) TWI776235B (es)
WO (1) WO2015191462A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201506343QA (en) 2013-02-22 2015-09-29 Genzyme Corp Microcarrier perfusion culturing methods and uses thereof
MX369522B (es) 2013-02-22 2019-11-11 Genzyme Corp Metodos de cultivo por perfusión con microportadores y usos de los mismos.
TW202204596A (zh) 2014-06-06 2022-02-01 美商健臻公司 灌注培養方法及其用途
TWI776235B (zh) 2014-06-09 2022-09-01 美商健臻公司 種子罐培養法(seed train processes)及其用途
IL253071B2 (en) 2014-12-22 2024-04-01 Genzyme Corp Methods for growing mammalian cells
JP2018532429A (ja) * 2015-10-26 2018-11-08 ロンザ リミテッド バイオ医薬品を生産するための製造設備
JP6973411B2 (ja) * 2016-12-22 2021-11-24 東亞合成株式会社 接着剤組成物並びにこれを用いたカバーレイフィルム、ボンディングシート、銅張積層板及び電磁波シールド材
EP3681989A1 (en) * 2017-09-15 2020-07-22 Bristol-Myers Squibb Company Online biomass capacitance monitoring during large scale production of polypeptides of interest
TWI898645B (zh) * 2018-05-04 2025-09-21 美商健臻公司 灌注式細胞培養裝置
US12071607B2 (en) * 2018-06-01 2024-08-27 Lonza Ltd. Midscale model for organic growth and phasing
EP3650528A1 (en) * 2018-11-08 2020-05-13 Aglaris Ltd Cell culture system and method
EA202191826A1 (ru) * 2019-01-25 2021-12-31 Энзен Биосайенсес Лимитед Автоматизированные комплексные непрерывные система и биопроцесс для продукции терапевтического белка
NZ777640A (en) * 2019-02-15 2025-11-28 Merck Sharp & Dohme Automated biomanufacturing systems, facilities, and processes
WO2020243006A1 (en) * 2019-05-24 2020-12-03 Rubius Therapeutics, Inc. Methods of generating enucleated erythroid cells
GB201908612D0 (en) * 2019-06-17 2019-07-31 Ge Healthcare Bio Sciences Ab A method for separating biomolecules
GB2599320B (en) * 2019-06-17 2024-10-23 Deka Products Lp System and method for cell and tissue preparation
JP7680418B2 (ja) * 2019-07-16 2025-05-20 イノベント バイオロジクス（スーチョウ）カンパニー，リミティド 高密度連続接種の細胞培養方法及びその応用
EP3831924A1 (en) * 2019-12-03 2021-06-09 Sartorius Stedim Data Analytics AB Adapting control of a cell culture in a production scale vessel with regard to a starting medium
CA3257876A1 (en) * 2022-06-28 2024-01-04 Amgen Inc. ADAPTIVE FACILITY CONFIGURATIONS FOR THE MANUFACTURING THERAPEUTIC PRODUCTS
KR20250058028A (ko) * 2022-09-06 2025-04-29 암젠 인크 대형 바이오리액터 시스템 및 방법
WO2024191993A2 (en) * 2023-03-13 2024-09-19 Amgen Inc. Systems and methods for seed train optimization

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
RU2058992C1 (ru) 1993-07-14 1996-04-27 Антипин Георгий Васильевич Способ получения кормового белка и устройство для его осуществления
DE19612966B4 (de) * 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
RU2215748C2 (ru) * 1999-04-09 2003-11-10 Сентро Де Инмунология Молекулар Способ получения рекомбинантного эритропоэтина человека и полученный эритропоэтин, фармацевтическая композиция
US6585971B1 (en) 1999-11-12 2003-07-01 Harbor-Ucla Research And Education Institute Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereof
DE60124780T2 (de) * 2000-12-20 2007-10-11 Bayer Pharmaceuticals Corp., West Haven Vorrichtung und verfahren zur serienvermehrung von säugerzellen zum animpfen
JP2005509406A (ja) 2001-05-09 2005-04-14 バイエル・フアーマシユーチカルズ・コーポレーシヨン 哺乳動物細胞株のための低温保存袋アセンブリー
WO2003020919A2 (en) 2001-08-31 2003-03-13 Bayer Healthcare Ag A unit and a process for carrying out high cell density fermentation
WO2003029442A1 (en) 2001-10-02 2003-04-10 Novo Nordisk Health Care Ag Method for production of recombinant proteins in eukaryote cells
WO2003039459A2 (en) 2001-11-05 2003-05-15 Genvec, Inc. Viral vector production methods and compositions
US6953692B2 (en) * 2001-12-18 2005-10-11 Bayer Pharmaceuticals Corporation Device and method for seed-train expansion of mammalian cells
US20050019914A1 (en) * 2003-07-24 2005-01-27 Aventis Pharma Deutschland Gmbh Perfusion process for producing erythropoietin
US20050186669A1 (en) 2004-02-20 2005-08-25 Cesco Bioengineering Co., Ltd. Apparatus and method for preparing and culturing cells
TWI384069B (zh) * 2004-08-27 2013-02-01 Pfizer Ireland Pharmaceuticals 多胜肽之製法
JP4914835B2 (ja) 2004-09-16 2012-04-11 ベクトン・ディキンソン・アンド・カンパニー 細胞培養用の潅流バイオリアクタ
DK1807101T3 (en) 2004-09-30 2016-05-23 Bayer Healthcare Llc Devices and methods for integrated continuous production of biological molecules
ES2662589T3 (es) 2005-06-15 2018-04-09 Zhejiang Jinyishengshi Bioengineering Co., Ltd. Recipientes para cultivo en suspensión
WO2006138143A1 (en) 2005-06-15 2006-12-28 Amprotein Corporation Suspension culture vessels
WO2008024769A2 (en) 2006-08-21 2008-02-28 Raven Biotechnologies, Inc. Intensified perfusion production method
WO2008073620A2 (en) 2006-11-02 2008-06-19 Neose Technologies, Inc. Manufacturing process for the production of polypeptides expressed in insect cell-lines
US8501462B2 (en) 2007-02-27 2013-08-06 The Board Of Trustees Of The University Of Illinois Insert device for multiwell plate
KR20100015363A (ko) * 2007-03-02 2010-02-12 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 단백질 생산의 개선
CN101678244B (zh) 2007-04-17 2013-06-19 深度控股有限公司 用于连续膜吸附的方法和装置
US9109193B2 (en) 2007-07-30 2015-08-18 Ge Healthcare Bio-Sciences Corp. Continuous perfusion bioreactor system
EP2188371B1 (en) * 2007-08-09 2017-12-20 Wyeth LLC Use of perfusion to enhance production of fed-batch cell culture in bioreactors
WO2009034186A2 (en) 2007-09-13 2009-03-19 Helmholtz-Zentrum für Infektionsforschung GmbH Process for cell cultivation
US20090233334A1 (en) 2008-03-11 2009-09-17 Excellgene Sa Cell cultivation and production of recombinant proteins by means of an orbital shake bioreactor system with disposable bags at the 1,500 liter scale
DE102008019691A1 (de) 2008-04-15 2009-10-29 Technische Universität Ilmenau Teilaktives mikrofluidisches System für die 3D-Zellkultivierung sowie Verfahren zu dessen Perfusion
CN101821378B (zh) 2008-06-16 2015-07-08 浙江金仪盛世生物工程有限公司 生物反应器
US8728479B2 (en) 2009-03-31 2014-05-20 The Trustees Of The University Of Pennsylvania Antigen-binding proteins comprising recombinant protein scaffolds
CN107043703B (zh) * 2009-07-06 2020-03-27 弗·哈夫曼-拉罗切有限公司 真核细胞的培养方法
CN105107228B (zh) * 2010-12-06 2017-03-29 颇尔公司 生物制品的连续加工方法
JP5995871B2 (ja) 2011-01-17 2016-09-21 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 分離装置およびその使用
US9163089B2 (en) 2011-05-12 2015-10-20 Probiogen Ag Enhancement of protein production yield mediated by a fast shuttling CDC42 GTPase
JP5897708B2 (ja) * 2011-07-01 2016-03-30 アムジエン・インコーポレーテツド 哺乳類細胞培養物
AR089231A1 (es) * 2011-12-15 2014-08-06 Amgen Inc Metodo de floculacion
WO2013116449A1 (en) 2012-02-02 2013-08-08 Corning Incorporated Automatic continuous perfusion cell culture microplate consumables
CN106399094A (zh) 2012-04-01 2017-02-15 Emd密理博公司 细胞培养和梯度迁移化验方法和装置
SG10201901708SA (en) * 2012-10-23 2019-03-28 Genzyme Corp Perfusion culturing methods and uses thereof
SG11201506343QA (en) 2013-02-22 2015-09-29 Genzyme Corp Microcarrier perfusion culturing methods and uses thereof
MX369522B (es) 2013-02-22 2019-11-11 Genzyme Corp Metodos de cultivo por perfusión con microportadores y usos de los mismos.
RU2768003C2 (ru) 2013-03-08 2022-03-22 Джензим Корпорейшн Интегрированное непрерывное производство терапевтических белковых лекарственных веществ
KR20210095233A (ko) 2013-03-15 2021-07-30 젠자임 코포레이션 고-밀도 세포 뱅킹 방법
HUE055888T2 (hu) 2013-09-16 2022-01-28 Genzyme Corp Eljárások és összeállítások sejttenyészet feldolgozására
EP3083933A1 (en) * 2013-12-20 2016-10-26 Biogen MA Inc. Use of perfusion seed cultures to improve biopharmaceutical fed-batch production capacity and product quality
TWI709569B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析樹脂及其用於製造方法的用途
TWI709570B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析法及製法
JP6695814B2 (ja) 2014-06-04 2020-05-20 アムジエン・インコーポレーテツド 哺乳類細胞培養物を回収するための方法
TW202204596A (zh) 2014-06-06 2022-02-01 美商健臻公司 灌注培養方法及其用途
TWI776235B (zh) 2014-06-09 2022-09-01 美商健臻公司 種子罐培養法(seed train processes)及其用途
CN104450597B (zh) 2014-12-10 2020-07-28 青岛农业大学 一种石油降解菌固体菌剂的制备方法及由其制备的固体菌剂修复石油污染的土壤的方法
IL253071B2 (en) 2014-12-22 2024-04-01 Genzyme Corp Methods for growing mammalian cells

Also Published As

Publication number Publication date
AU2023203734A1 (en) 2023-07-06
KR102584375B1 (ko) 2023-09-27
ES2773630T3 (es) 2020-07-13
AU2015274897B2 (en) 2021-11-04
JP6784600B2 (ja) 2020-11-11
JP2021019621A (ja) 2021-02-18
RU2694327C2 (ru) 2019-07-11
CN111575225B (zh) 2023-09-08
IL249452B (en) 2021-04-29
TW201610148A (zh) 2016-03-16
IL249452A0 (en) 2017-02-28
EP3858983C0 (en) 2025-07-16
AU2015274897A1 (en) 2017-01-12
JP2022120031A (ja) 2022-08-17
IL290096B1 (en) 2023-12-01
TWI776235B (zh) 2022-09-01
SG11201610216UA (en) 2017-01-27
TWI707949B (zh) 2020-10-21
BR112016028891B1 (pt) 2023-04-11
AU2021245116B2 (en) 2023-07-27
TW202246486A (zh) 2022-12-01
CA2951551A1 (en) 2015-12-17
JP2017521057A (ja) 2017-08-03
EP3858983A1 (en) 2021-08-04
EP3152299A1 (en) 2017-04-12
US10570367B2 (en) 2020-02-25
MX2020004073A (es) 2020-07-29
EP3858983B1 (en) 2025-07-16
EP3628730A1 (en) 2020-04-01
AU2021245116A1 (en) 2021-10-28
JP7360504B2 (ja) 2023-10-12
DK3152299T3 (da) 2020-02-24
CA2951551C (en) 2023-02-28
US20200377850A1 (en) 2020-12-03
IL281626A (en) 2021-05-31
CN111575225A (zh) 2020-08-25
IL281626B (en) 2022-03-01
CN106574249A (zh) 2017-04-19
MX2016016301A (es) 2017-04-06
EP3152299B1 (en) 2019-11-20
CN106574249B (zh) 2020-05-08
IL290096B2 (en) 2024-04-01
WO2015191462A1 (en) 2015-12-17
TW202102658A (zh) 2021-01-16
RU2016151316A3 (es) 2018-11-15
RU2016151316A (ru) 2018-07-10
US20150353896A1 (en) 2015-12-10
IL290096A (en) 2022-03-01
CY1122803T1 (el) 2021-05-05
KR102416402B1 (ko) 2022-07-04
BR112016028891A2 (pt) 2017-08-22
ES3043610T3 (en) 2025-11-25
HUE047683T2 (hu) 2020-05-28
KR20220098051A (ko) 2022-07-08
KR20170015472A (ko) 2017-02-08
JP7089000B2 (ja) 2022-06-21
RU2019119708A (ru) 2019-07-03

Similar Documents

Publication Publication Date Title
MX373323B (es) Procesos de siembra en serie y usos de los mismos.
PT3727460T (pt) Ligandos peptídicos bicíclicos específicos para epha2
PH12020550781A1 (en) Anti-jagged1 antibodies and methods of use
CL2016001871A1 (es) Anticuerpos humanos para pd-1
PH12017500877B1 (en) ANTI-CD79b ANTIBODIES AND METHODS OF USE
EP3547968A4 (en) PROSTHESIS OBTAINED BY TISSUE ENGINEERING
PH12016501894B1 (en) Anti-ox40 antibodies and methods of use
MA40579A (fr) Anticorps anti-cll-1 et immunoconjugués
MY192927A (en) Fused bicyclic compounds for the treatment of disease
LT3240801T (lt) Kombinuota navikų imunoterapija
ECSP17015977A (es) Terapia de combinacion
CO2017004314A2 (es) Compuestos anti-tnf
MX2016015162A (es) Anticuerpos anti - gpc3 e inmunoconjugados.
MX2017008456A (es) Compuestos biciclicos fusionados para el tratamiento de enfermedades.
DK3612624T3 (da) Genterapi
MX2023006416A (es) Anticuerpos, usos y metodos.
EP3424940A4 (en) Radiolabeled drug
MX2017005975A (es) Anticuerpos anti factor de crecimiento derivado de plaquetas b (pdgf-b) y metodos de uso.
DK3105320T3 (da) Syntetisk nethinde
MX2020012893A (es) Formulaciones de proteinas.
DK3207164T3 (da) Halvkontinuerlige dyrkningsfremgangsmåder
DK3122763T3 (da) Antimikrobielle peptiddendrimerer
MY167383A (en) Disposable diaper
EP3632505C0 (en) NON-INVASIVE NEUROMODULATION
SG11201607717QA (en) Therapeutic instrument

Legal Events

Date Code Title Description
FG Grant or registration